- Investigator
- Carl J Pepine
Clinical trials
-
Women's Evaluation of Systemic Aging Tenacity [SCORE: MAE-WEST]-Project 2 -
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy for Limited mCRC(ERASur) This phase III trial compares total ablative therapy and usual systemic therapy to usual systemic therapy alone in treating patients with colorectal cancer that has spread to up to 4 body sites (limited metastatic). The usual approach for patients…
- Investigator
- Kathryn E Hitchcock
- Ages
- 18 Years - N/A
- Sexes
- All
-
BIIB059 In this study, researchers will learn more about a study drug called litifilimab (BIIB059) in participants with systemic lupus erythematosus (SLE). The study will focus on participants who have active disease and are already taking standard of care…
- Investigator
- Michael R Bubb
- Ages
- 18 Years - N/A
- Sexes
- All
-
OCEANIC Researchers are looking for a better way to treat people with atrial fibrillation and prevent stroke or systemic embolism (blood clots travelling through the blood stream to plug another vessel). Atrial fibrillation is a condition of having…
- Investigator
- Gabriel Bonnell
- Ages
- 18 Years - N/A
- Sexes
- All
-
VITALISScE This study is open to adults aged 18 and older or above legal age who have systemic sclerosis. People can participate if they have a specific subtype called diffuse cutaneous systemic sclerosis. People with another subtype called limited cutaneous…
- Investigator
- Michael R Bubb
- Ages
- 18 Years - N/A
- Sexes
- All
-
PROMISE III A prospective, single-arm, multi-center study designed to gather additional information on the LimFlow System.
- Investigator
- Benjamin N Jacobs
- Ages
- 18 Years - 95 Years
- Sexes
- All
-
TS MOD CM GPI The investigators will implant and monitor 8 research subjects with a subcortical closed-loop system for detection and suppression of tics. The project will use the FDA-approved "Medtronic Percept PC" device, which is an implantable neurostimulator…
- Investigator
- Michael S Okun
- Ages
- 18 Years - 85 Years
- Sexes
- All
-
EXPAND II Obtain safety and effectiveness data to support indication expansion for the Medtronic TAVR System to include patients with moderate, symptomatic AS.
- Investigator
- Thomas M Beaver
- Ages
- 65 Years - N/A
- Sexes
- All
-
RECOVER VITAL This study is a platform protocol designed to be flexible so that it is suitable for a wide range of settings within health care systems and in community settings where it can be integrated into COVID-19 programs and subsequent treatment plans. This…
- Ages
- 18 Years - N/A
- Sexes
- All
-
RECOVER-NEURO This platform protocol is designed to be flexible so that it is suitable for a wide range of settings within health care systems, for remote settings, and in community settings where it can be integrated into COVID-19 programs and subsequent…
- Ages
- 18 Years - N/A
- Sexes
- All